COMMUNIQUÉS West-GlobeNewswire

Human Appeal Launches Birmingham’s First ‘Third Space’ Community Hub in Sparkhill
01/10/2025
BIRMINGHAM, United Kingdom, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Human Appeal, one of the UK’s leading humanitarian aid charities, today announces the launch of its first-ever community hub in Birmingham, ‘The Third Space [...]
IntusCare Announces Major Implementation Milestone for CareHub EMR, Achieving Successful Go-Lives Across Diverse PACE Programs
01/10/2025
IntusCare’s milestone highlights how CareHub empowers PACE teams to deliver smarter, compliant, and participant-centered care from day one. Providence, Rhode Island, Oct. 01, 2025 (GLOBE NEWSWIRE) -- IntusCare , a [...]
Health-ISAC® Marks 15 Years of Protecting the Global Health Sector
01/10/2025
ORLANDO, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Health-ISAC (Health Information Sharing and Analysis Center), a trusted community that is the go-to source of timely, actionable, and relevant information for the global [...]
Folia Health Secures $10.5M in Funding to Transform Healthcare and Research With Patient-Reported Information
01/10/2025
Series A investment will advance the company’s efforts to give patients the power to drive research on rare diseases and chronic conditions BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Folia Health , the patient-driven [...]
OPA: Compromising Safety in the Name of Access
01/10/2025
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ontario’s mental health system is already under immense pressure, and the Ontario Psychological Association (OPA) warns that lowering professional standards will only make [...]
Her Natural Edge and In Her Corner Launch Conversational AI Companions to Support Menopause Awareness
01/10/2025
Alexandria, VA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Her Natural Edge and In Her Corner announced the launch of Valerie and Jordan, two conversational voice companions developed to provide information and support around [...]
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
01/10/2025
NEW HAVEN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that two [...]
Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine
01/10/2025
Pilot study evaluates safety and tolerability of implantable neuromodulation therapy for erectile dysfunction following radical prostatectomy LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a [...]
Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
01/10/2025
LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher disease, at the European [...]
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
01/10/2025
– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – – FLT3 mutations occur in approximately 30% of newly diagnosed [...]
Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
01/10/2025
Awarded contract base period of US$3.6 million to fund vaccine manufacturing with additional option periods to advance development through Phase 1 trials Submitted up to US$97 million in additional U.S. government [...]
Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers
01/10/2025
BROOMFIELD, Colo., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
CLEVELAND, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
01/10/2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to [...]
SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
01/10/2025
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. [...]
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
01/10/2025
- Meeting date aligns with prior guidance - - FDA to review AEON’s analytical development plan and initial data - IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: [...]
Solid Biosciences to Present at Upcoming Scientific Meetings
01/10/2025
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from [...]
ATMA CENA Grows National Mental Health Network to 13 Clinics
01/10/2025
Expanding access to safe, regulated psychedelic-assisted therapy across Canada CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ATMA CENA, a Canadian mental health company specializing in psychedelic-assisted therapy [...]
Stryker to announce financial results for its third quarter of fiscal year 2025
01/10/2025
Portage, Michigan, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its third quarter of fiscal year 2025 on Thursday, October 30, 2025. A press release will be [...]

Pages